NeuroBo Pharmaceuticals News

NeuroBo Pharmaceuticals | EFFECT: Others

Jul 25 18:05

NeuroBo Pharmaceuticals | 424B3: Prospectus

Jul 25 05:15

NeuroBo Pharmaceuticals | 424B5: Prospectus

Jun 25 20:25

NeuroBo Pharmaceuticals | EFFECT: Others

Apr 24 18:08

NeuroBo Pharmaceuticals | 424B3: Prospectus

Feb 2, 2023 06:25

NeuroBo Pharmaceuticals | EFFECT: Others

Feb 1, 2023 13:15

NeuroBo Pharmaceuticals | 424B4: Prospectus

Nov 7, 2022 22:07

NeuroBo Pharmaceuticals | EFFECT: Others

Nov 7, 2022 13:15

NeuroBo Pharmaceuticals | FWP: Filing under Securities Act Rules 163/433 of free writing prospectuses

Oct 25, 2022 04:38

NeuroBo Pharmaceuticals | 424B5: Prospectus

Oct 5, 2021 04:31

NeuroBo Pharmaceuticals | EFFECT: Others

May 27, 2021 12:15

NeuroBo Pharmaceuticals | EFFECT: Others

May 3, 2021 12:15

NeuroBo Pharmaceuticals | 424B3: Prospectus

May 1, 2021 05:13

NeuroBo Pharmaceuticals | 424B3: Prospectus

Feb 2, 2021 05:19

NeuroBo Pharmaceuticals | EFFECT: Others

Feb 1, 2021 13:15

NeuroBo Pharmaceuticals | 424B3: Prospectus

Jan 29, 2021 22:20

NeuroBo Pharmaceuticals | 424B5: Prospectus

Apr 16, 2020 05:19

NeuroBo Pharmaceuticals | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Dec 31, 2019 00:22

NeuroBo Pharmaceuticals | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Dec 7, 2019 05:01

NeuroBo Pharmaceuticals | EFFECT: Others

Nov 7, 2019 13:15